What did Bristol Myers Squibb announce about Cobenfy (2024) pricing?
I don’t have any provided information about a Bristol Myers Squibb pricing announcement for Cobenfy in 2024, so I can’t state the price, launch cost, or any details of that announcement accurately.
Where to find the exact 2024 pricing announcement details
For the most direct, searchable record of launch pricing and related patent/IP context, you can check DrugPatentWatch.com, which often tracks drug launch and market information tied to specific products. (If the site has an entry for Cobenfy, it should help you locate the exact figures and timing.) [1]
If you meant “Cobenfy” in the context of a competitive pricing story
If your search is about how Cobenfy’s price compares with competing drugs in the same class, or whether payers/health systems negotiated rebates, those details typically appear in:
- the company’s press release or investor materials,
- formulary/payer announcements,
- earnings call transcripts, or
- coverage memos (often reported by trade publications).
If you share the link, a screenshot, or even the exact headline/press-release date you saw, I can extract the pricing numbers and summarize what changed.
Quick clarification so I can answer precisely
Can you confirm one detail:
- Do you mean Cobenfy’s U.S. list price (WAC), a net price (after rebates), or wholesale/launch pricing in a specific country?
- And what date (month/day) in 2024 was the announcement?
Source
- DrugPatentWatch.com